Abstract
Nonsteroidal anti-inflammatory drugs (NSAIDs) are one of the most prescribed drugs worldwide and, like any medication, can cause adverse drug reactions. Since NSAIDs belonging to the group of coxibs, are quite commonly used in clinical practice now, the study of the safety of this class of drugs is given the highest priority. The paper analyzes a largest-scale PRECISION study of the safety of NSAIDs, the aim of which was to assess the cardiovascular safety of celecoxib versus that of ibuprofen and naproxen in patients with osteoarthritis and rheumatoid arthritis
Highlights
Нестероидные противовоспалительные препараты (НПВП) являются одними из наиболее назначаемых лекарственных средств в мире и, как и любое лекарственное средство, могут вызывать развитие нежелательных лекарственных реакций
Results of the PRECISION study: Could an answer be given to the question of how safe coxibs versus traditional Nonsteroidal anti-inflammatory drugs (NSAIDs) are in treating patients at high risk for cardiovascular events? Dovgan E.V
Results of the PRECISION study: Could an answer be given to the question of how safe coxibs versus traditional NSAIDs are in treating patients at high risk for cardiovascular events? Sovremennaya Revmatologiya = Modern Rheumatology Journal.2017;11(3)
Summary
Нестероидные противовоспалительные препараты (НПВП) являются одними из наиболее назначаемых лекарственных средств в мире и, как и любое лекарственное средство, могут вызывать развитие нежелательных лекарственных реакций. В статье проанализированы результаты одного из наиболее масштабных исследований, посвященного изучению безопасности НПВП, – PRECISION, целью которого была оценка сердечно-сосудистой безопасности целекоксиба в сравнении с ибупрофеном и напроксеном у пациентов с остеоартритом и ревматоидным артритом.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
